KLKuan-Ting Lin

Kuan-Ting Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kuan-Ting Lin has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Supplementary Figure S1-S11 and Table S1 from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuan-Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Figure S1. Elevated SRSF1 induces pancreatitis and is associated with its duration. Figure S2. Elevated SRSF1 predicts poor PDAC clinical prognosis and is associated with PDAC progression. Figure S3. SRSF1 accelerates KRASG12D-mediated PDAC tumorigenesis. Figure S4. SRSF1 loss delays KRASG12D-mediated PDAC initiation. Figure S5. Opposite patterns of pathway enrichment by KRASG12D mutation versus SRSF1 upregulation. Figure S6. Recombination and activation of KrasG12D allele in pancreas cells from KC mice. Figure S7. KSC and KPSC mice exhibit a hyper-activated MAPK pathway, suppression of which diminished SRSF1-induced pancreatitis. Figure S8. Decreased SRSF1 expression perturbs MAPK signaling. Figure S9. MYC promotes SRSF1 expression in PDAC. Figure S10. SRSF1 regulates IL1R1 alternative splicing and expression. Figure S11. Knockout of Il1r1 rescues SRSF1-induced pancreatitis. Table S1. Oligonucleotides for PCR and short hairpin RNAs.

  • Open Access

    Data from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuan-Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Inflammation is strongly associated with pancreatic ductal adenocarcinoma (PDAC), a highly lethal malignancy. Dysregulated RNA splicing factors have been widely reported in tumorigenesis, but their involvement in pancreatitis and PDAC is not well understood. Here, we report that the splicing factor SRSF1 is highly expressed in pancreatitis, PDAC precursor lesions, and tumors. Increased SRSF1 is sufficient to induce pancreatitis and accelerate KRASG12D-mediated PDAC. Mechanistically, SRSF1 activates MAPK signaling—partly by upregulating interleukin 1 receptor type 1 (IL1R1) through alternative-splicing-regulated mRNA stability. Additionally, SRSF1 protein is destabilized through a negative feedback mechanism in phenotypically normal epithelial cells expressing KRASG12D in mouse pancreas and in pancreas organoids acutely expressing KRASG12D, buffering MAPK signaling and maintaining pancreas cell homeostasis. This negative feedback regulation of SRSF1 is overcome by hyperactive MYC, facilitating PDAC tumorigenesis. Our findings implicate SRSF1 in the etiology of pancreatitis and PDAC, and point to SRSF1-misregulated alternative splicing as a potential therapeutic target.Significance:We describe the regulation of splicing factor SRSF1 expression in the context of pancreas cell identity, plasticity, and inflammation. SRSF1 protein downregulation is involved in a negative feedback cellular response to KRASG12D expression, contributing to pancreas cell homeostasis. Conversely, upregulated SRSF1 promotes pancreatitis and accelerates KRASG12D-mediated tumorigenesis through enhanced IL1 and MAPK signaling.This article is highlighted in the In This Issue feature, p. 1501

  • Open Access

    Data from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuang-Ting Lin, Mohammad Alinoor. Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Inflammation is strongly associated with pancreatic ductal adenocarcinoma (PDAC), a highly lethal malignancy. Dysregulated RNA splicing factors have been widely reported in tumorigenesis, but their involvement in pancreatitis and PDAC is not well understood. Here, we report that the splicing factor SRSF1 is highly expressed in pancreatitis, PDAC precursor lesions, and tumors. Increased SRSF1 is sufficient to induce pancreatitis and accelerate KRASG12D-mediated PDAC. Mechanistically, SRSF1 activates MAPK signaling—partly by upregulating interleukin 1 receptor type 1 (IL1R1) through alternative-splicing-regulated mRNA stability. Additionally, SRSF1 protein is destabilized through a negative feedback mechanism in phenotypically normal epithelial cells expressing KRASG12D in mouse pancreas, and in pancreas organoids acutely expressing KRASG12D, buffering MAPK signaling and maintaining pancreas-cell homeostasis. This negative-feedback regulation of SRSF1 is overcome by hyperactive MYC, facilitating PDAC tumorigenesis. Our findings implicate SRSF1 in the etiology of pancreatitis and PDAC, and point to SRSF1-misregulated alternative splicing as a potential therapeutic target.

  • Open Access

    Supplementary Figure S1-S11 and Table S1 from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuang-Ting Lin, Mohammad Alinoor. Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Figure S1. Elevated SRSF1 induces pancreatitis and is associated with its duration. Figure S2. Elevated SRSF1 predicts poor PDAC clinical prognosis and is associated with PDAC progression. Figure S3. SRSF1 accelerates KRASG12D-mediated PDAC tumorigenesis. Figure S4. SRSF1 loss delays KRASG12D-mediated PDAC initiation. Figure S5. Opposite patterns of pathway enrichment by KRASG12D mutation versus SRSF1 upregulation. Figure S6. Recombination and activation of KrasG12D allele in pancreas cells from KC mice. Figure S7. KSC and KPSC mice exhibit a hyper-activated MAPK pathway, suppression of which diminished SRSF1-induced pancreatitis. Figure S8. Decreased SRSF1 expression perturbs MAPK signaling. Figure S9. MYC promotes SRSF1 expression in PDAC. Figure S10. SRSF1 regulates IL1R1 alternative splicing and expression. Figure S11. Knockout of Il1r1 rescues SRSF1-induced pancreatitis. Table S1. Oligonucleotides for PCR and short hairpin RNAs.

  • Open Access

    Supplementary Figure S1-S11 and Table S1 from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuang-Ting Lin, Mohammad Alinoor. Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Figure S1. Elevated SRSF1 induces pancreatitis and is associated with its duration. Figure S2. Elevated SRSF1 predicts poor PDAC clinical prognosis and is associated with PDAC progression. Figure S3. SRSF1 accelerates KRASG12D-mediated PDAC tumorigenesis. Figure S4. SRSF1 loss delays KRASG12D-mediated PDAC initiation. Figure S5. Opposite patterns of pathway enrichment by KRASG12D mutation versus SRSF1 upregulation. Figure S6. Recombination and activation of KrasG12D allele in pancreas cells from KC mice. Figure S7. KSC and KPSC mice exhibit a hyper-activated MAPK pathway, suppression of which diminished SRSF1-induced pancreatitis. Figure S8. Decreased SRSF1 expression perturbs MAPK signaling. Figure S9. MYC promotes SRSF1 expression in PDAC. Figure S10. SRSF1 regulates IL1R1 alternative splicing and expression. Figure S11. Knockout of Il1r1 rescues SRSF1-induced pancreatitis. Table S1. Oligonucleotides for PCR and short hairpin RNAs.

  • Open Access

    Supplementary Figure S1-S11 and Table S1 from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuan-Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Figure S1. Elevated SRSF1 induces pancreatitis and is associated with its duration. Figure S2. Elevated SRSF1 predicts poor PDAC clinical prognosis and is associated with PDAC progression. Figure S3. SRSF1 accelerates KRASG12D-mediated PDAC tumorigenesis. Figure S4. SRSF1 loss delays KRASG12D-mediated PDAC initiation. Figure S5. Opposite patterns of pathway enrichment by KRASG12D mutation versus SRSF1 upregulation. Figure S6. Recombination and activation of KrasG12D allele in pancreas cells from KC mice. Figure S7. KSC and KPSC mice exhibit a hyper-activated MAPK pathway, suppression of which diminished SRSF1-induced pancreatitis. Figure S8. Decreased SRSF1 expression perturbs MAPK signaling. Figure S9. MYC promotes SRSF1 expression in PDAC. Figure S10. SRSF1 regulates IL1R1 alternative splicing and expression. Figure S11. Knockout of Il1r1 rescues SRSF1-induced pancreatitis. Table S1. Oligonucleotides for PCR and short hairpin RNAs.

  • Open Access

    Supplementary Figure S1-S11 and Table S1 from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuan-Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Figure S1. Elevated SRSF1 induces pancreatitis and is associated with its duration. Figure S2. Elevated SRSF1 predicts poor PDAC clinical prognosis and is associated with PDAC progression. Figure S3. SRSF1 accelerates KRASG12D-mediated PDAC tumorigenesis. Figure S4. SRSF1 loss delays KRASG12D-mediated PDAC initiation. Figure S5. Opposite patterns of pathway enrichment by KRASG12D mutation versus SRSF1 upregulation. Figure S6. Recombination and activation of KrasG12D allele in pancreas cells from KC mice. Figure S7. KSC and KPSC mice exhibit a hyper-activated MAPK pathway, suppression of which diminished SRSF1-induced pancreatitis. Figure S8. Decreased SRSF1 expression perturbs MAPK signaling. Figure S9. MYC promotes SRSF1 expression in PDAC. Figure S10. SRSF1 regulates IL1R1 alternative splicing and expression. Figure S11. Knockout of Il1r1 rescues SRSF1-induced pancreatitis. Table S1. Oligonucleotides for PCR and short hairpin RNAs.

  • Open Access

    Data from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuan-Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Inflammation is strongly associated with pancreatic ductal adenocarcinoma (PDAC), a highly lethal malignancy. Dysregulated RNA splicing factors have been widely reported in tumorigenesis, but their involvement in pancreatitis and PDAC is not well understood. Here, we report that the splicing factor SRSF1 is highly expressed in pancreatitis, PDAC precursor lesions, and tumors. Increased SRSF1 is sufficient to induce pancreatitis and accelerate KRASG12D-mediated PDAC. Mechanistically, SRSF1 activates MAPK signaling—partly by upregulating interleukin 1 receptor type 1 (IL1R1) through alternative-splicing-regulated mRNA stability. Additionally, SRSF1 protein is destabilized through a negative feedback mechanism in phenotypically normal epithelial cells expressing KRASG12D in mouse pancreas and in pancreas organoids acutely expressing KRASG12D, buffering MAPK signaling and maintaining pancreas cell homeostasis. This negative feedback regulation of SRSF1 is overcome by hyperactive MYC, facilitating PDAC tumorigenesis. Our findings implicate SRSF1 in the etiology of pancreatitis and PDAC, and point to SRSF1-misregulated alternative splicing as a potential therapeutic target.Significance:We describe the regulation of splicing factor SRSF1 expression in the context of pancreas cell identity, plasticity, and inflammation. SRSF1 protein downregulation is involved in a negative feedback cellular response to KRASG12D expression, contributing to pancreas cell homeostasis. Conversely, upregulated SRSF1 promotes pancreatitis and accelerates KRASG12D-mediated tumorigenesis through enhanced IL1 and MAPK signaling.This article is highlighted in the In This Issue feature, p. 1501

  • Open Access

    Supplementary Figure S1-S11 and Table S1 from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuan-Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Figure S1. Elevated SRSF1 induces pancreatitis and is associated with its duration. Figure S2. Elevated SRSF1 predicts poor PDAC clinical prognosis and is associated with PDAC progression. Figure S3. SRSF1 accelerates KRASG12D-mediated PDAC tumorigenesis. Figure S4. SRSF1 loss delays KRASG12D-mediated PDAC initiation. Figure S5. Opposite patterns of pathway enrichment by KRASG12D mutation versus SRSF1 upregulation. Figure S6. Recombination and activation of KrasG12D allele in pancreas cells from KC mice. Figure S7. KSC and KPSC mice exhibit a hyper-activated MAPK pathway, suppression of which diminished SRSF1-induced pancreatitis. Figure S8. Decreased SRSF1 expression perturbs MAPK signaling. Figure S9. MYC promotes SRSF1 expression in PDAC. Figure S10. SRSF1 regulates IL1R1 alternative splicing and expression. Figure S11. Knockout of Il1r1 rescues SRSF1-induced pancreatitis. Table S1. Oligonucleotides for PCR and short hairpin RNAs.

  • Open Access

    Supplementary Figure S1-S11 and Table S1 from Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

    by Ledong Wan, Kuan-Ting Lin, Mohammad Alinoor Rahman, Yuma Ishigami, Zhikai Wang, Mads A. Jensen, John E. Wilkinson, Youngkyu Park, David A. Tuveson, Adrian R. Krainer

    Figure S1. Elevated SRSF1 induces pancreatitis and is associated with its duration. Figure S2. Elevated SRSF1 predicts poor PDAC clinical prognosis and is associated with PDAC progression. Figure S3. SRSF1 accelerates KRASG12D-mediated PDAC tumorigenesis. Figure S4. SRSF1 loss delays KRASG12D-mediated PDAC initiation. Figure S5. Opposite patterns of pathway enrichment by KRASG12D mutation versus SRSF1 upregulation. Figure S6. Recombination and activation of KrasG12D allele in pancreas cells from KC mice. Figure S7. KSC and KPSC mice exhibit a hyper-activated MAPK pathway, suppression of which diminished SRSF1-induced pancreatitis. Figure S8. Decreased SRSF1 expression perturbs MAPK signaling. Figure S9. MYC promotes SRSF1 expression in PDAC. Figure S10. SRSF1 regulates IL1R1 alternative splicing and expression. Figure S11. Knockout of Il1r1 rescues SRSF1-induced pancreatitis. Table S1. Oligonucleotides for PCR and short hairpin RNAs.